CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Makunje Moses SEE REMARKS | Grant or award · Stock Option (Right to Buy) | +224,439 | 224,439 | ||
| 2026-02-27 | Liu Dongfang CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +748,130 | 748,130 | ||
| 2026-02-27 | Hanley David C. CHIEF TECHNICAL OPERATIONS | Grant or award · Stock Option (Right to Buy) | +748,130 | 748,130 | ||
| 2026-02-27 | Markel Stacy CHIEF PEOPLE OFFICER | Grant or award · Stock Option (Right to Buy) | +748,130 | 748,130 | ||
| 2026-02-27 | Hattersley Gary CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +748,130 | 748,130 | ||
| 2026-02-27 | Cui Xiangmin Director | Grant or award · Stock Option (Right to Buy) | +74,813 | 74,813 | ||
| 2026-02-27 | Wentworth Kerry CHIEF REGULATORY OFFICER | Grant or award · Stock Option (Right to Buy) | +748,130 | 748,130 | ||
| 2026-02-27 | Hung David PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +1,995,012 | 1,995,012 | ||
| 2025-12-01 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise | +150,000 | $2.93 | $440K | 168,000 |
| 2025-12-01 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −150,000 | $7.82 | $1.2M | 18,000 |
| 2025-12-01 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) | −150,000 | 165,000 | ||
| 2025-11-26 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise | +10,000 | $3.61 | $36K | 28,000 |
| 2025-11-26 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −10,000 | $8.00 | $80K | 18,000 |
| 2025-11-26 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) | −10,000 | 470,000 | ||
| 2025-11-25 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise | +10,000 | $3.61 | $36K | 28,000 |
| 2025-11-25 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −10,000 | $7.50 | $75K | 18,000 |
| 2025-11-25 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) | −10,000 | 480,000 | ||
| 2025-11-20 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise | +20,000 | $1.87 | $37K | 38,000 |
| 2025-11-20 | Liu Dongfang CHIEF MEDICAL OFFICER | Sale | −20,000 | $7.00 | $140K | 18,000 |
| 2025-11-20 | Liu Dongfang CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) | −20,000 | 450,000 |
Page 3 of 15 · 291 trades